Trials / Completed
CompletedNCT04498065
MYocardial DOmmages Related to COVID-19
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 273 (actual)
- Sponsor
- Centre Hospitalier Universitaire Dijon · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Myocardial injury, as assessed by elevation of cardiac troponins (Tnc), is frequent among patients with COVID-19. Although rare autopsy cases reported COVID-19 related myocardial inflammation, the origin of Tnc elevation is unknown to date. Several cardiac causes, such as myocarditis, non-ischemic myocardial injury (NIMI), or myocardial infarction (MI) may lead to Tnc kinetic. Our work will test the hypothesis that during SARS-Cov2 infection, the elevation of cardiac biomarkers could be linked to the occurrence of myocarditis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Biological data | Biological data |
| OTHER | Clinical data | Clinical data |
Timeline
- Start date
- 2020-03-01
- Primary completion
- 2022-05-31
- Completion
- 2022-05-31
- First posted
- 2020-08-04
- Last updated
- 2022-09-22
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT04498065. Inclusion in this directory is not an endorsement.